Hepatocellular carcinoma, obesity and the PNPLA3 I148M genetic variant

被引：0
|
作者：
机构：
来源：
Nature Reviews Gastroenterology & Hepatology | 2012年 / 9卷 / 8期
关键词：
D O I：
10.1038/nrgastro.2012.129
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：426 / 426
相关论文
共 50 条
  • [31] PNPLA3 I148M polymorphism and liver damage in obese children
    Valenti, Luca
    Nobili, Valerio
    JOURNAL OF PEDIATRICS, 2011, 159 (05): : 876 - 876
  • [32] Global Epidemiological Impact of PNPLA3 I148M on Liver Disease
    Kozlitina, Julia
    Sookoian, Silvia
    LIVER INTERNATIONAL, 2024,
  • [33] Impact of PNPLA3 I148M on Clinical Outcomes in Patients With MASLD
    Petta, Salvatore
    Armandi, Angelo
    Bugianesi, Elisabetta
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [34] PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes
    Karamfilova, Vera
    Gateva, Antoaneta
    Assyov, Yavor
    Alexiev, Asen
    Savov, Alexey
    Yaneva, Nadejda
    Ivanova, Irena
    Ivanova-Boyanova, Radina
    Ivanova, Raya
    Vlahova, Zlatina
    Mateva, Ludmila
    Kamenov, Zdravko
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (04) : 433 - 438
  • [35] The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis
    Shen, Jian-Hua
    Li, Yi-Ling
    Li, Dan
    Wang, Ning-Ning
    Jing, Lei
    Huang, Yu-Hong
    JOURNAL OF LIPID RESEARCH, 2015, 56 (01) : 167 - 175
  • [36] The rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia
    Sydykova, Lubov A.
    Kurtanov, Khariton A.
    Borisova, Natalia V.
    Pavlova, Nadejda I.
    Stepanov, Konstantin M.
    Markova, Sardana V.
    Makarov, Albert D.
    Alekseeva, Sardana N.
    Antipina, Uliana D.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2018, 8 (03) : 201 - 205
  • [37] PNPLA3 I148M Involved in Mechanism of Variability in Antilipogenesis Response to Exenatide
    Chen, Yunzhi
    Liang, Hua
    Xu, Fen
    DIABETES, 2020, 69
  • [38] The I148M PNPLA3 variant mitigates Niacin beneficial effects: How the genetic screening in NAFLD patients gains value
    Paolini, E.
    Longo, M.
    Meroni, M.
    Malaspina, G.
    De Caro, E. R.
    Cespiati, A.
    Lombardi, R.
    Fracanzani, A. L.
    Dongiovanni, P.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S29 - S30
  • [39] PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review
    Boeckmans, Joost
    Gatzios, Alexandra
    Schattenberg, Joern M.
    Koek, Ger H.
    Rodrigues, Robim M.
    Vanhaecke, Tamara
    LIVER INTERNATIONAL, 2023, 43 (05) : 975 - 988
  • [40] Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease
    Valenti, Luca
    Dongiovanni, Paola
    HEPATOLOGY, 2017, 66 (04) : 1026 - 1028
12345